AgenDx Biosciences

AgendX

The company develops molecular diagnostic tests to detect pancreatic cancer for healthcare providers and patients.

NX Pharmagen

This company develops molecular diagnostic tests and imaging agents for physicians and healthcare payers to improve cancer and maternal-fetal health outcomes.

AnchorDx

This company develops non-invasive liquid biopsy tests and diagnostic tools for early cancer screening, diagnosis and recurrence monitoring for healthcare providers and patients.

Valius

This company develops molecular diagnostic platforms to identify therapeutic options for patients with rare and advanced cancers.

Avant Genomics

The company develops an automated platform for liquid biopsy sample preparation to assist clinical laboratories in cancer detection and monitoring.

StatDx

This company develops point-of-care molecular diagnostic systems for healthcare providers to identify infectious diseases and critical care conditions.

MultiplexDX

This company develops molecular diagnostic tests and reagents for oncologists and research institutions to improve cancer profiling and infectious disease detection.

Elphogene

This biotechnology company develops a molecular liquid biopsy test to monitor cancer progression and treatment efficacy for oncology patients and healthcare professionals.